Study conduct, monitoring and data management in a trinational trial: the OPTIMA model
- 1 June 2004
- journal article
- research article
- Published by SAGE Publications in Clinical Trials
- Vol. 1 (3) , 277-281
- https://doi.org/10.1191/1740774504cn022oa
Abstract
The OPTions In Management with Antiretrovirals (OPTIMA) Trial, a collaboration between three governmental agencies in the USA, UK and Canada is a large-scale, multicenter, randomized controlled trial designed to compare the relative efficacy of different therapeutic strategies in HIV disease. The collaboration of three coordinating centers introduced unique data management issues including: a) use of different data systems for managing “country” trial data; b) two-way data transfer between the coordinating centers and the center where OPTIMA data is merged and analysis files are generated; and c) translation of certain data forms (mainly patient completed questionnaires) into French and Spanish. The involvement of three data centers provided a challenge in planning, designing and executing data management procedures in OPTIMA. Processes were implemented to ensure the trial's successful execution at the trinational level, without disregarding countryspecific requirements and regulations. The OPTIMA model required a significant time and resource investment on behalf of all agencies involved, but allowed for autonomy and a sense of joint ownership of data in different countries.Keywords
This publication has 5 references indexed in Scilit:
- An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2×2×2×2×2×2 factorial design (IMPACT)Controlled Clinical Trials, 2003
- An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA TrialControlled Clinical Trials, 2003
- The Evaluation of Subcutaneous Proleukin® (interleukin-2) in a Randomized International TrialControlled Clinical Trials, 2002
- The Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) Study: Rationale and DesignControlled Clinical Trials, 2001
- Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS)Controlled Clinical Trials, 1993